Halozyme Therapeutics Inc (HALO)

[jamtomorrow2]

We still don’t have the retrospective analysis of the PEG results vs control in the high HA patients. If those results aren’t in favour of PEG then that would take some explaining.

Of course we’re all assuming that the PEG/Gem trial is being extended due to the PEG arm patients doing so well. What if it’s the control arm doing well like in Ffox trial? Just shows nothing is certain in the life of a HALO Investor. The PEG arm side effect issues also look worrying high in the Ffox trial, which led to a high drop out rate of PEG patients. What if that’s also happening in the Gem trial, which could explain the extended numbers. Lots to worry about eh?